Pazopanib and sunitinib trigger autophagic and non-autophagic death of bladder tumour cells.
about
Sunitinib-induced morpho-functional changes and drug effectiveness in malignant solitary fibrous tumoursPazopanib and HDAC inhibitors interact to kill sarcoma cells.Autophagy Inhibition Enhances Sunitinib Efficacy in Clear Cell Ovarian CarcinomaReactive Oxygen Species-Mediated Mechanisms of Action of Targeted Cancer TherapyAutophagy inhibition sensitizes hepatocellular carcinoma to the multikinase inhibitor linifanib.Combination of Cl‑IB‑MECA with paclitaxel is a highly effective cytotoxic therapy causing mTOR‑dependent autophagy and mitotic catastrophe on human melanoma cells.Autophagy induction by silibinin positively contributes to its anti-metastatic capacity via AMPK/mTOR pathway in renal cell carcinomaCrizotinib induces autophagy through inhibition of the STAT3 pathway in multiple lung cancer cell linesResistance to sunitinib in renal clear cell carcinoma results from sequestration in lysosomes and inhibition of the autophagic fluxSESN2/sestrin 2 induction-mediated autophagy and inhibitory effect of isorhapontigenin (ISO) on human bladder cancersAutophagy Modulation in Disease Therapy: Where Do We Stand?Antitumor effect of sunitinib in human prostate cancer cells functions via autophagy.The route to personalized medicine in bladder cancer: where do we stand?Sunitinib activates Axl signaling in renal cell cancer.Targeting the VEGF pathway in metastatic bladder cancer.Sunitinib induces genomic instability of renal carcinoma cells through affecting the interaction of LC3-II and PARP-1.Autophagy, a double-edged sword in anti-angiogenesis therapy.Incorporating VEGF-targeted therapy in advanced urothelial cancer.Alternative scheduling of pulsatile, high dose sunitinib efficiently suppresses tumor growthThe anticancer drug sunitinib promotes autophagyand protects from neurotoxicity in an HIV-1 Tat model of neurodegeneration.Sorafenib induces cathepsin B-mediated apoptosis of bladder cancer cells by regulating the Akt/PTEN pathway. The Akt inhibitor, perifosine, enhances the sorafenib-induced cytotoxicity against bladder cancer cells.Combination treatment with fasudil and clioquinol produces synergistic anti-tumor effects in U87 glioblastoma cells by activating apoptosis and autophagy.Pulsatile high-dose treatment with antiangiogenic tyrosine kinase inhibitors improves clinical antitumor activity.From Resistance to Sensitivity: Insights and Implications of Biphasic Modulation of Autophagy by Sunitinib.A novel multikinase inhibitor R8 exhibits potent inhibition on cancer cells through both apoptosis and autophagic cell death.
P2860
Q33433105-3DE757F9-0550-4FF2-8EB9-068357F13658Q33631472-1C163E7C-672B-43BF-952A-184CE45046F0Q33746474-1BC2DC23-1387-4BBA-833A-8F4DE1334BE2Q33862425-1162D611-24B2-4DA0-9618-32490A35BA36Q34366102-DA43C2C5-A0F1-4EBB-9A5B-195DD448CAEEQ35128510-A19897C7-7F7F-44E5-90EC-89DEF18FF1D1Q35585683-1FFDE10F-8033-4D09-9001-BA1DC9DCC621Q36545596-D34DB593-E17D-423C-B521-4A5D9B7508CDQ36777194-92DA9429-E82C-4304-9268-21891A54F4C7Q37141782-602F6CF1-9DDC-4D01-AE7F-D64EA64450FCQ37512290-90E56FB0-02F1-40F4-910D-E79EAA94FA03Q37734570-30F1497E-74DB-4214-B757-44DCAF944F2DQ38337192-903EF56D-8530-4042-BAB8-47EB786D2E24Q38451761-0B7210EF-440C-40AA-8188-22FAA4D1EB9FQ38534167-37263043-5025-4CA3-BB0C-6B3B2B238125Q38630696-4E53B395-C9B3-4F3B-9C74-567DB1BFABB9Q38682453-0654F5BE-E90E-4AA0-B068-2E616D0804B8Q38756931-432A629F-736A-4A40-A1C5-4D42780E06ECQ39413595-D6F6E994-54EF-4FBF-967C-0773CBBC33E4Q40364671-D73048F7-4E1F-443D-AEF9-3BA9B0C1B669Q41770394-2FB0CB14-8CE4-455F-AC91-2188A35AA5F8Q41916031-761B135F-6B22-4D70-BCB7-1C2410697A3AQ42333847-BF2F58B3-8C35-4C65-BA47-0AEE9C36502FQ42700492-360D1D72-A768-4934-9256-70BEC1083FB6Q44869860-75EA4B28-32DC-4886-94C1-5212674EC4AE
P2860
Pazopanib and sunitinib trigger autophagic and non-autophagic death of bladder tumour cells.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Pazopanib and sunitinib trigge ...... death of bladder tumour cells.
@en
Pazopanib and sunitinib trigge ...... death of bladder tumour cells.
@nl
type
label
Pazopanib and sunitinib trigge ...... death of bladder tumour cells.
@en
Pazopanib and sunitinib trigge ...... death of bladder tumour cells.
@nl
prefLabel
Pazopanib and sunitinib trigge ...... death of bladder tumour cells.
@en
Pazopanib and sunitinib trigge ...... death of bladder tumour cells.
@nl
P2093
P2860
P50
P356
P1476
Pazopanib and sunitinib trigge ...... death of bladder tumour cells.
@en
P2093
A M Eleuteri
C Amantini
L Burattini
M B Morelli
S Liberati
V Farfariello
P2860
P2888
P304
P356
10.1038/BJC.2013.420
P407
P577
2013-07-25T00:00:00Z
P5875
P6179
1027682984